Close

More on AMGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-2.3% Growth)
- Ratings (5.3 Score)
- Holders
- Dividends (3.4% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (5/2/24)
- Ex-Dividend (5/16/2024)
- M&A (N/A)
- M&A (12/31/22 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AMGN Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 3.49B
Marketable securities 34.5B
Trade receivables, net 3.19B
Inventories 2.68B
Other current assets 2B
Total current assets 45.84B
Property, plant and equipment, net 4.91B
Intangible assets, net
Goodwill 14.8B
Other assets 1.9B
Total assets 78.15B
Current liabilities:
Accounts payable 825M
Accrued liabilities 4.92B
Current portion of convertible notes
Total current liabilities 10.54B
Convertible notes
Other long-term debt
Other non-current liabilities 3.9B
Contingencies and commitments
Stockholders' equity:
Common stock and additional paid-in capital; $0.0001 par value; 2,750 shares authorized; outstanding - 932 shares in 2010 and 995 shares in 2009
Accumulated deficit 221M
Accumulated other comprehensive income -139M
Total stockholders' equity 30.77B
Total liabilities and stockholders' equity 78.15B